Maze Therapeutics Inc. – Indentures Watch

from 8-K 17 pages Form of Pre-Funded Warrant to Purchase Common Stock

from 10-K 6 pages Description of Capital Stock

from S-3ASR 33 pages Maze Therapeutics, Inc. and , as Trustee Indenture Dated as of ,

from S-3ASR 5 pages Form of Debt Security

from 8-K 17 pages Form of Pre-Funded Warrant to Purchase Common Stock

from S-1/A 2 pages The Corporation Shall Furnish Without Charge to Each Stockholder Who So Requests a Statement of the Powers, Designations, Preferences and Relative, Participating, Optional or Other Special Rights of Each Class of Stock of the Corporation or Series Thereof and the Qualifications, Limitations or Restrictions of Such Preferences and/or Rights. Such Requests Shall Be Made to the Corporation’s Secretary at the Principal Office of the Corporation. Keep This Certificate in a Safe Place. if It Is Lost, Stolen, or Destroyed the Corporation Will Require a Bond Indemnity as a Condition to the Issuance of a Replacement Certificate. the Following Abbreviations, When Used in the Inscription on the Face of This Certificate, Shall Be Construed as Though They Were Written Out in Full According to Applicable Laws or Regulations

from S-1 56 pages Maze Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement November 26, 2024

from DRS/A 56 pages Maze Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement November 26, 2024

from DRS/A 55 pages Maze Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement December 8, 2021

from DRS 10 pages Maze Therapeutics, Inc. Subordinated Convertible Promissory Note

from DRS 54 pages Maze Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement December 8, 2021